1094101-31-1Relevant academic research and scientific papers
Twin medicine type HMG-CoA reductase inhibiting agent and synthesis method thereof
-
Paragraph 0022; 0023; 0024; 0055; 0056; 0057, (2017/10/18)
The invention belongs to the technical field of medicine chemistry, and particularly relates to a first-class twin medicine type HMG-CoA reductase inhibiting agent and a synthesis method thereof. The preparation method of the novel twin medicine type HMG-CoA reductase inhibiting agent has the advantages that the reaction steps are simple; no pollution exists; the method is suitable for industrial scaled application; the activity of the HMG-CoA reductase inhibiting agent is obviously superior to that of positive control medicine.
COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS
-
Page/Page column 46-47, (2009/01/23)
Disclosed herein are novel compositions and methods for treating or preventing a variety of disorders and conditions associated with lipid metabolism. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising one or more fibric acid or statin derivative compositions alone or in combination with one or more lipid altering agents and/or PDE inhibitors.
